Citation Le Blanc R. Cellules tumorales circulantes dans les cas de cancer du sein : utilisation clinique du test CellSearch®. [Circulating tumour cells in breast cancer: clinical use of the CellSearch® test] Quebec: Institut national d'excellence en sante et en services sociaux (INESSS). Note informative. 2016 Authors' conclusions Based on the scientific literature identified, the use of CellSearch® tests as a predictive and prognostic biomarker in patients with early-stage breast cancer is not justified. The evidence is insufficient for establishing a concrete association between the presence of CTCs pre- and post treatment and patient survival. In the case of patients with metastatic breast cancer, the examination of the scientific literature suggests that CTC enumeration prior to treatment could be a prognostic biomarker for patient survival. Despite the prognostic value of CTC enumeration, based on studies, its clinical utility has yet to be confirmed. Indexing Status Subject indexing assigned by CRD MeSH Breast Neoplasms; Diagnosis; Humans; Neoplastic Cells, Circulating Country of organisation Canada English summary An English language summary is available. Address for correspondence Institut national d'excellence en santé et en services sociaux (INESSS), 1195 avenue Lavigerie, bureau 60 Québec (Québec) Canada, G1V 4N3
Email: inesss@inesss.qc.ca AccessionNumber 32017000012 Date abstract record published 03/01/2017 |